APGE
Price:
$75.5
Market Cap:
$4.14B
Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts.
Industry
Biotechnology
IPO Date
2023-07-14
Stock Exchange
NASDAQ
Ticker
APGE
According to Apogee Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 15.86. This represents a change of -4.71% compared to the average of 16.65 of the last 4 quarters.
The mean historical Current Ratio of Apogee Therapeutics, Inc. over the last ten years is 17.72. The current 15.86 Current Ratio has changed 8.85% with respect to the historical average. Over the past ten years (40 quarters), APGE's Current Ratio was at its highest in in the March 2024 quarter at 38.08. The Current Ratio was at its lowest in in the March 2022 quarter at 0.
Average
17.72
Median
18.55
Minimum
15.24
Maximum
19.38
Discovering the peaks and valleys of Apogee Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 27.20%
Maximum Annual Current Ratio = 19.38
Minimum Annual Increase = -4.30%
Minimum Annual Current Ratio = 15.24
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 18.55 | -4.30% |
| 2023 | 19.38 | 27.20% |
The current Current Ratio of Apogee Therapeutics, Inc. (APGE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
17.72
5-year avg
17.72
10-year avg
17.72
Apogee Therapeutics, Inc.’s Current Ratio is greater than Centessa Pharmaceuticals plc (10.12), greater than Xenon Pharmaceuticals Inc. (15.14), greater than ASCENTAGE PHARMA GROUP INTERNATIONAL (1.54), greater than Ultragenyx Pharmaceutical Inc. (1.89), greater than Celcuity Inc. (12.26), greater than Zai Lab Limited (3.12), less than CG Oncology, Inc. Common stock (22.79), greater than Legend Biotech Corporation (4.71), less than Soleno Therapeutics, Inc. (16.08), less than Disc Medicine, Inc. (23.45),
| Company | Current Ratio | Market cap |
|---|---|---|
| 10.12 | $3.97B | |
| 15.14 | $3.45B | |
| 1.54 | $2.85B | |
| 1.89 | $3.52B | |
| 12.26 | $4.90B | |
| 3.12 | $2.21B | |
| 22.79 | $3.35B | |
| 4.71 | $2.56B | |
| 16.08 | $2.83B | |
| 23.45 | $3.54B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Apogee Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Apogee Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Apogee Therapeutics, Inc.'s Current Ratio?
How is the Current Ratio calculated for Apogee Therapeutics, Inc. (APGE)?
What is the highest Current Ratio for Apogee Therapeutics, Inc. (APGE)?
What is the 3-year average Current Ratio for Apogee Therapeutics, Inc. (APGE)?
What is the 5-year average Current Ratio for Apogee Therapeutics, Inc. (APGE)?
How does the current Current Ratio for Apogee Therapeutics, Inc. (APGE) compare to its historical average?